Buys
Open market- Shares
- +81,550
- Avg price
- $12.22
- Total value
- +$996,859
Ashley Cordova - Former Chief Executive Officer at NovoCure Ltd
Issuer-level insider activity
- Role
- Former Chief Executive Officer
- Issuer ticker
- NVCR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Ashley Cordova in NovoCure Ltd
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +81,550
- Share %
- 100%
- Total value
- +$996,859
Reported holdings for Ashley Cordova in NovoCure Ltd
Form 4 holding
Former Chief Executive Officer
NovoCure Ltd
- Security class
- Ordinary Shares
- Shares / value
- 422,570
- Estimated value
- $5,294,802
- Report date
- 04 Mar 2026
- Price
- $12.53
- Ownership
- Direct
Form 4 holding
Former Chief Executive Officer
NovoCure Ltd
- Security class
- Stock Options (Right to buy)
- Shares / value
- 224,123
- Estimated value
- $4,076,797
- Report date
- 04 Mar 2025
- Price
- $18.19
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Ashley Cordova in NovoCure Ltd
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.